---
document_datetime: 2025-11-23 08:09:03
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/truberzi.html
document_name: truberzi.html
version: success
processing_time: 0.1079742
conversion_datetime: 2025-12-26 11:14:42.095868
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Truberzi

[RSS](/en/individual-human-medicine.xml/66135)

##### Withdrawn

This medicine's authorisation has been withdrawn

eluxadoline

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Truberzi](#news-on)
- [Related content](#related-content-625)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 18 December 2020 the European Commission withdrew the marketing authorisation for Truberzi (eluxadoline) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Allergan Pharmaceuticals International Limited, which notified the European Commission of its decision to discontinue the marketing of the product for commercial reasons.

Truberzi was granted marketing authorisation in the EU on 19 September 2016 for the treatment of irritable bowel syndrome with diarrhoea. The marketing authorisation was initially valid for a 5-year period. The product had not been marketed in the EU since 2018.

The European Public Assessment Report (EPAR) for Truberzi is updated to indicate that the marketing authorisation is no longer valid.

Truberzi : EPAR - Summary for the public

Reference Number: EMA/CHMP/517539/2016

English (EN) (632.55 KB - PDF)

**First published:** 29/09/2016

**Last updated:** 25/02/2021

[View](/en/documents/overview/truberzi-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-161)

български (BG) (658.78 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/bg/documents/overview/truberzi-epar-summary-public_bg.pdf)

español (ES) (632.15 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/es/documents/overview/truberzi-epar-summary-public_es.pdf)

čeština (CS) (657.3 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/cs/documents/overview/truberzi-epar-summary-public_cs.pdf)

dansk (DA) (631.54 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/da/documents/overview/truberzi-epar-summary-public_da.pdf)

Deutsch (DE) (632.88 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/de/documents/overview/truberzi-epar-summary-public_de.pdf)

eesti keel (ET) (629.29 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/et/documents/overview/truberzi-epar-summary-public_et.pdf)

ελληνικά (EL) (660.58 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/el/documents/overview/truberzi-epar-summary-public_el.pdf)

français (FR) (632.93 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/fr/documents/overview/truberzi-epar-summary-public_fr.pdf)

hrvatski (HR) (649.91 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/hr/documents/overview/truberzi-epar-summary-public_hr.pdf)

italiano (IT) (631.92 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/it/documents/overview/truberzi-epar-summary-public_it.pdf)

latviešu valoda (LV) (653.3 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/lv/documents/overview/truberzi-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (657.41 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/lt/documents/overview/truberzi-epar-summary-public_lt.pdf)

magyar (HU) (653.4 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/hu/documents/overview/truberzi-epar-summary-public_hu.pdf)

Malti (MT) (656.52 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/mt/documents/overview/truberzi-epar-summary-public_mt.pdf)

Nederlands (NL) (631.78 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/nl/documents/overview/truberzi-epar-summary-public_nl.pdf)

polski (PL) (658.69 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/pl/documents/overview/truberzi-epar-summary-public_pl.pdf)

português (PT) (632.41 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/pt/documents/overview/truberzi-epar-summary-public_pt.pdf)

română (RO) (651.82 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/ro/documents/overview/truberzi-epar-summary-public_ro.pdf)

slovenčina (SK) (654.11 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/sk/documents/overview/truberzi-epar-summary-public_sk.pdf)

slovenščina (SL) (649.22 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/sl/documents/overview/truberzi-epar-summary-public_sl.pdf)

Suomi (FI) (629.39 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/fi/documents/overview/truberzi-epar-summary-public_fi.pdf)

svenska (SV) (629.96 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/sv/documents/overview/truberzi-epar-summary-public_sv.pdf)

Truberzi : EPAR - Risk-management-plan summary

English (EN) (733.27 KB - PDF)

**First published:** 26/03/2019

**Last updated:** 25/02/2021

[View](/en/documents/rmp-summary/truberzi-epar-risk-management-plan-summary_en.pdf)

## Product information

Truberzi : EPAR - Product Information

English (EN) (1.63 MB - PDF)

**First published:** 29/09/2016

**Last updated:** 25/02/2021

[View](/en/documents/product-information/truberzi-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-30)

български (BG) (3 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/bg/documents/product-information/truberzi-epar-product-information_bg.pdf)

español (ES) (1.58 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/es/documents/product-information/truberzi-epar-product-information_es.pdf)

čeština (CS) (2.58 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/cs/documents/product-information/truberzi-epar-product-information_cs.pdf)

dansk (DA) (1.61 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/da/documents/product-information/truberzi-epar-product-information_da.pdf)

Deutsch (DE) (1.62 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/de/documents/product-information/truberzi-epar-product-information_de.pdf)

eesti keel (ET) (1.59 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/et/documents/product-information/truberzi-epar-product-information_et.pdf)

ελληνικά (EL) (3.13 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/el/documents/product-information/truberzi-epar-product-information_el.pdf)

français (FR) (1.65 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/fr/documents/product-information/truberzi-epar-product-information_fr.pdf)

hrvatski (HR) (1.81 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/hr/documents/product-information/truberzi-epar-product-information_hr.pdf)

íslenska (IS) (1.71 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/is/documents/product-information/truberzi-epar-product-information_is.pdf)

italiano (IT) (1.68 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/it/documents/product-information/truberzi-epar-product-information_it.pdf)

latviešu valoda (LV) (2.7 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/lv/documents/product-information/truberzi-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.86 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/lt/documents/product-information/truberzi-epar-product-information_lt.pdf)

magyar (HU) (2.55 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/hu/documents/product-information/truberzi-epar-product-information_hu.pdf)

Malti (MT) (2.73 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/mt/documents/product-information/truberzi-epar-product-information_mt.pdf)

Nederlands (NL) (1.69 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/nl/documents/product-information/truberzi-epar-product-information_nl.pdf)

norsk (NO) (1.66 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/no/documents/product-information/truberzi-epar-product-information_no.pdf)

polski (PL) (2.67 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/pl/documents/product-information/truberzi-epar-product-information_pl.pdf)

português (PT) (1.74 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/pt/documents/product-information/truberzi-epar-product-information_pt.pdf)

română (RO) (386.01 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/ro/documents/product-information/truberzi-epar-product-information_ro.pdf)

slovenčina (SK) (2.57 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/sk/documents/product-information/truberzi-epar-product-information_sk.pdf)

slovenščina (SL) (2.5 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/sl/documents/product-information/truberzi-epar-product-information_sl.pdf)

Suomi (FI) (1.6 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/fi/documents/product-information/truberzi-epar-product-information_fi.pdf)

svenska (SV) (1.64 MB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/sv/documents/product-information/truberzi-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IAIN/0013 12/02/2020

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Truberzi : EPAR - All Authorised presentations

English (EN) (575.78 KB - PDF)

**First published:** 29/09/2016

**Last updated:** 25/02/2021

[View](/en/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-55)

български (BG) (596.62 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/bg/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_bg.pdf)

español (ES) (576.1 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/es/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_es.pdf)

čeština (CS) (582.17 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/cs/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (574.73 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/da/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (574.68 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/de/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (574.84 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/et/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (596.72 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/el/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_el.pdf)

français (FR) (574.52 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/fr/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (582.33 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/hr/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (574.37 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/is/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_is.pdf)

italiano (IT) (574.37 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/it/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (594.07 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/lv/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (594.78 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/lt/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (631.34 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/hu/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (589.69 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/mt/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (574.36 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/nl/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (574.34 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/no/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_no.pdf)

polski (PL) (583.38 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/pl/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_pl.pdf)

português (PT) (574.48 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/pt/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_pt.pdf)

română (RO) (591 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/ro/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (582.54 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/sk/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (581.28 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/sl/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (575.79 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/fi/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (574.21 KB - PDF)

**First published:**

29/09/2016

**Last updated:**

25/02/2021

[View](/sv/documents/all-authorised-presentations/truberzi-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Truberzi Active substance eluxadoline International non-proprietary name (INN) or common name eluxadoline Therapeutic area (MeSH)

- Irritable Bowel Syndrome
- Diarrhea

Anatomical therapeutic chemical (ATC) code A07

### Pharmacotherapeutic group

Antidiarrheals, intestinal antiinflammatory / antiinfective agents

### Therapeutic indication

Truberzi is indicated in adults for the treatment of irritable bowel syndrome with diarrhoea (IBS D).

## Authorisation details

EMA product number EMEA/H/C/004098 Marketing authorisation holder

Allergan Pharmaceuticals International Limited

Clonshaugh Industrial Estate

Opinion adopted 21/07/2016 Marketing authorisation issued 19/09/2016 Withdrawal of marketing authorisation 18/12/2020 Revision 6

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Truberzi : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (730.18 KB - PDF)

**First published:** 05/01/2017

**Last updated:** 25/02/2021

[View](/en/documents/procedural-steps-after/truberzi-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Truberzi-H-C-PSUSA-00010528-201703 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Reference Number: EMA/833234/2017

English (EN) (688.77 KB - PDF)

**First published:** 14/12/2017

**Last updated:** 25/02/2021

[View](/en/documents/scientific-conclusion/truberzi-h-c-psusa-00010528-201703-epar-scientific-conclusions-and-grounds-variation-terms-marketing-authorisation_en.pdf)

## Initial marketing authorisation documents

Truberzi : EPAR - Public assessment report

Adopted

Reference Number: EMA/549473/2016

English (EN) (2.86 MB - PDF)

**First published:** 29/09/2016

**Last updated:** 25/02/2021

[View](/en/documents/assessment-report/truberzi-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Truberzi

Adopted

Reference Number: EMA/CHMP/467320/2016

English (EN) (635.45 KB - PDF)

**First published:** 22/07/2016

**Last updated:** 25/02/2021

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-truberzi_en.pdf)

#### News on Truberzi

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 July 2016](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-18-21-july-2016) 22/07/2016

#### Related content

- [Clinical data](https://clinicaldata.ema.europa.eu/web/cdp/home?p_p_id=cdpdossierviewportlet_WAR_cdpdossierviewportlet=0=maximized=view=column-3=2=EMEAHC0040980000) (initial marketing authorisation)

**This page was last updated on** 25/02/2021

## Share this page

[Back to top](#main-content)